Hyperhomocysteinemia accelerates atherosclerosis through a B cell–derived anti-β2 glycoprotein I–mediated endothelial injury
Hyperhomocysteinemia (HHcy) accelerates atherosclerosis through immunometabolic and inflammatory mechanisms. Previous studies have shown that HHcy promotes the production of B cell–derived anti-β2 glycoprotein I (β2GPI) antibodies, which enhance macrophage inflammatory activation. However, whether HHcy-induced an...